Evaluating safety and pharmacokinetics of TPM XR as adjunctive therapy in pediatric epilepsy

Description:
Seizures are abnormal electrical impulses in the brain. The signs and symptoms of seizures vary depending on the type of seizure a patient has. This study is looking at the use of an extended release form of topiramate in pediatric patients with epilepsy

Medication Under Study:
topiramate extended release (TPM XR)

Full study title:
Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as
Adjunctive Therapy in Pediatric Subjects with Epilepsy

IRB Study ID:
110309


Who may qualify:

Patients ages 4-17 with a diagnosis of epilepsy currently being treated with topiramate

Who does not qualify:

Patients with certain medical conditions or taking certain medications

If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute, 330-543-5012

For urgent patient care matters involving a current study patient, please call: 330-920-5774


Lead Principal Investigator:

Photo
Thomas Enlow, MD
Pediatric Neurologist


Bookmark and Share

iGrow iGrow
Sign up for our parent enewsletter
    Contact Us

    330-543-5012

    E-mail

    find a location
    Find a location Type the first 3-5 letters of a specialty, service or location:
    Or, view: a map, a list of all locations, locations by city or locations near me.
    find a doctor
    Find a doctor Type the first 3-5 letters of the name, location or specialty:
    Or, view a list of all doctors by name, location and specialty.